Search

everythinglearnresearchcommunity

for

Search:↓

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

RU 58841 may treat acne, hair loss, and excessive hair growth.

The gummy improved hair growth and reduced shedding in women.

Niosomal minoxidil was found to be more effective in increasing hair count and patient satisfaction than conventional minoxidil in treating hair loss.

The ketoconazole gel improved hair growth and is a promising treatment for hair loss.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

A new hyaluronan-based biomatrix successfully supports the growth of mouse ovarian follicles, producing healthy eggs.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

The cream effectively and safely reduces facial hair in women.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Androstanediol glucuronide is a reliable marker for hirsutism in women.